Rupee likely to test 94.50 levels in near term: Report

IANS | October 12, 2026 7:16 PM

New Delhi, Oct 12 (IANS) The Indian currency could test the Rs 94.50 level per dollar in the short term even as foreign exchange reserves remain adequate, but long‑term structural measures by the government are indispensable to revive capital inflows, a report said on Monday.

'Western nations overlook pace of India’s transition to non-fossil fuels'

IANS | October 12, 2026 6:24 PM

New Delhi, Oct 12 (IANS) While western countries continue to focus on India’s coal-fired power plants in the debate on climate change, what is being overlooked is the rapid rate at which the country is adding to its renewable energy capacity, which includes both solar, hydel, and wind power, an article said.

Resale‑led China’s housing rebound is hollow narrative: Report

IANS | October 12, 2026 5:56 PM

New Delhi, Oct 12 (IANS) China’s housing market has been framed as stabilising in recent months, but the recovery is fragile and driven largely by resales rather than new construction, which could leave broader economic strains intact, a new report has said.

China struggles to lure foreign AI talent despite incentives: Report

IANS | October 12, 2026 5:24 PM

New Delhi, Oct 12 (IANS) As the United States and China intensify their competition for leadership in artificial intelligence (AI), a new study has found that China is struggling to attract foreign researchers even as it ramps up recruitment efforts through special visas, research grants and other incentives, a report has said.

Q2FY27 earnings seen mixed amid demand momentum: Report

IANS | October 12, 2026 4:57 PM

New Delhi, Oct 12 (IANS) The second quarter of FY27 -- July-September -- is likely to see differentiated earnings across sectors with demand momentum supporting select industries even as input-cost pressures persist, according to a report released on Monday.

Centre to cap trade margins on cancer drugs, SC calls for broader price review

IANS | October 12, 2026 4:36 PM

New Delhi, Oct 12 (IANS) The Centre on Monday informed the Supreme Court that it has decided to regulate trade margins on anti-cancer medicines by capping them at 30 per cent of the maximum retail price (MRP), while the apex court called for a broader review of medicine pricing across the pharmaceutical sector.